Fig. 4From: The development of a highly sensitive and quantitative SARS-CoV-2 rapid antigen test applying newly developed monoclonal antibodies to an automated chemiluminescent flow-through membrane immunoassay deviceAntibody affinity determination by SPRBack to article page